Cargando…

Tailoring the Implementation of New Biomarkers Based on Their Added Predictive Value in Subgroups of Individuals

BACKGROUND: The value of new biomarkers or imaging tests, when added to a prediction model, is currently evaluated using reclassification measures, such as the net reclassification improvement (NRI). However, these measures only provide an estimate of improved reclassification at population level. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Giessen, A., Moons, K. G. M., de Wit, G. A., Verschuren, W. M. M., Boer, J. M. A., Koffijberg, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306488/ https://www.ncbi.nlm.nih.gov/pubmed/25622035 http://dx.doi.org/10.1371/journal.pone.0114020

Ejemplares similares

Interpretation of CVD risk predictions in clinical practice: Mission impossible?
por: Lagerweij, G. R., et al.
Publicado: (2019)

A new selection method to increase the health benefits of CVD prevention strategies
por: Lagerweij, Ghizelda R, et al.
Publicado: (2018)

On the assessment of the added value of new predictive biomarkers
por: Chen, Weijie, et al.
Publicado: (2013)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage?
por: Debray, Thomas P. A., et al.
Publicado: (2013)

From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study
por: Koffijberg, Hendrik, et al.
Publicado: (2013)

Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device
por: Wolkorte, Ria, et al.
Publicado: (2021)

Pomegranate Peel as Suitable Source of High-Added Value Bioactives: Tailored Functionalized Meat Products
por: Gullón, Patricia, et al.
Publicado: (2020)

Rational and combinatorial tailoring of bioactive cyclic dipeptides
por: Giessen, Tobias W., et al.
Publicado: (2015)

Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study
por: Elias, Sjoerd G., et al.
Publicado: (2016)

Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
por: Geersing, G J, et al.
Publicado: (2014)

Understanding Starch Metabolism in Pea Seeds towards Tailoring Functionality for Value-Added Utilization
por: Yu, Bianyun, et al.
Publicado: (2021)

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals
por: Ponchel, Frederique, et al.
Publicado: (2022)

Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model
por: Snell, Kym I.E., et al.
Publicado: (2016)

Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
por: Boyd, Lenka N.C., et al.
Publicado: (2022)

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
por: van Delft, Frederik, et al.
Publicado: (2020)

Determinants for the implementation of person-centered tools for workers with chronic health conditions: a mixed-method study using the Tailored Implementation for Chronic Diseases checklist
por: Zipfel, N., et al.
Publicado: (2021)

What is the added value of FeNO as T2 biomarker?
por: Marcos, María Celeste, et al.
Publicado: (2022)

Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion
por: Kihira, Shingo, et al.
Publicado: (2021)

Subgroup identification in clinical trials via the predicted individual treatment effect
por: Ballarini, Nicolás M., et al.
Publicado: (2018)

A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant
por: Sun, Hong, et al.
Publicado: (2013)

Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia
por: Oudart, Jean-Baptiste, et al.
Publicado: (2020)

No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome
por: Poldervaart, Judith M., et al.
Publicado: (2015)

Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA)
por: Geersing, G.-J., et al.
Publicado: (2018)

Tailoring the chiral magnetic interaction between two individual atoms
por: Khajetoorians, A. A., et al.
Publicado: (2016)

Implementing Individually Tailored Prescription of Physical Activity in Routine Clinical Care: Protocol of the Physicians Implement Exercise = Medicine (PIE=M) Development and Implementation Project
por: Krops, Leonie A, et al.
Publicado: (2020)

Quantifying the added value of new biomarkers: how and how not
por: Cook, Nancy R.
Publicado: (2018)

Adding value to real-world data: the role of biomarkers
por: Plant, Darren, et al.
Publicado: (2020)

Incorporating published univariable associations in diagnostic and prognostic modeling
por: A Debray, Thomas P, et al.
Publicado: (2012)

The added value of text from Dutch general practitioner notes in predictive modeling
por: Seinen, Tom M, et al.
Publicado: (2023)

AD cycle: specification and implementation
por: Mulder, H, et al.
Publicado: (1999)

Markers for the non-invasive diagnosis of mesothelioma: a systematic review
por: van der Bij, S, et al.
Publicado: (2011)

Editorial: Tailoring in implementation science
por: Albers, Bianca, et al.
Publicado: (2023)

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
por: Collins, G S, et al.
Publicado: (2015)

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial
por: Geersing, Geert-Jan, et al.
Publicado: (2020)

Risk reclassification analysis investigating the added value of fatigue to sickness absence predictions
por: Roelen, Corné A. M., et al.
Publicado: (2015)

An individualized hemodynamic optimization: Tailoring the targets of therapy
por: Magoon, Rohan, et al.
Publicado: (2020)

Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review
por: Brands, Henrike Jacoba, et al.
Publicado: (2023)

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement
por: Collins, Gary S., et al.
Publicado: (2015)

The Nipple–Areola Preserving Mastectomy: The Value of Adding a Delay Procedure
por: Martinez, Carlos A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8e5feqpsu640lefu5tsm52hgqq